wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38164431-D6785D52-0389-4E0D-86E0-2D1E65B1469A
Q38164431-D6785D52-0389-4E0D-86E0-2D1E65B1469A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38164431-D6785D52-0389-4E0D-86E0-2D1E65B1469A
The adverse effects profile of levetiracetam in epilepsy: a more detailed look.
P2860
Q38164431-D6785D52-0389-4E0D-86E0-2D1E65B1469A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38164431-D6785D52-0389-4E0D-86E0-2D1E65B1469A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c2f2b07b8aafbb686ca2c3a4120d399a468e98ef
P2860
A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.